University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Thomas Lietman, M.D.

Ophthalmologist

Clinics

Sjögren's Syndrome Clinic
521 Parnassus Ave., Room C-646
San Francisco, CA 94143
Phone: (415) 476-2045
Fax: (415) 514-2862

Hours: Monday to Friday
8:30 a.m. – noon
1:30 p.m. – 4:30 p.m.

Conditions & Treatments

More about Thomas Lietman

Education

Columbia University 1990

Selected Research and Publications

  1. Keenan JD, Hotez PJ, Amza A, Stoller NE, Gaynor BD, Porco TC, Lietman TM. Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts. PLoS Negl Trop Dis. 2013; 7(12):e2562.
  2. Mascarenhas J, Lalitha P, Prajna NV, Srinivasan M, Das M, D'Silva SS, Oldenburg CE, Borkar DS, Esterberg EJ, Lietman TM, Keenan JD. Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features. Am J Ophthalmol. 2014 Jan; 157(1):56-62.
  3. Haile M, Tadesse Z, Gebreselassie S, Ayele B, Gebre T, Yu SN, Stoller NE, Gaynor BD, Porco TC, Emerson PM, Lietman TM, Keenan JD. The association between latrine use and trachoma: a secondary cohort analysis from a randomized clinical trial. Am J Trop Med Hyg. 2013 Oct; 89(4):717-20.
  4. Prajna NV, O'Brien KS, Acharya NR, Lietman TM. Voriconazole for fungal keratitis. Ophthalmology. 2013 Sep; 120(9):e62-3.
  5. West SK, Bailey R, Munoz B, Edwards T, Mkocha H, Gaydos C, Lietman T, Porco T, Mabey D, Quinn TC. A randomized trial of two coverage targets for mass treatment with azithromycin for trachoma. PLoS Negl Trop Dis. 2013; 7(8):e2415.
  6. Prajna NV, Srinivasan M, Lalitha P, Krishnan T, Rajaraman R, Ravindran M, Mascarenhas J, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM. Differences in clinical outcomes in keratitis due to fungus and bacteria. JAMA Ophthalmol. 2013 Aug; 131(8):1088-9.
  7. Burr SE, Hart JD, Edwards T, Baldeh I, Bojang E, Harding-Esch EM, Holland MJ, Lietman TM, West SK, Mabey DC, Sillah A, Bailey RL. Association between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The Gambia. PLoS Negl Trop Dis. 2013; 7(7):e2347.
  8. Liu F, Porco TC, Ray KJ, Bailey RL, Mkocha H, Muņoz B, Quinn TC, Lietman TM, West SK. Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity. PLoS Negl Trop Dis. 2013; 7(7):e2303.
  9. Sun CQ, Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Srinivasan M, Raghavan A, O'Brien KS, Ray KJ, McLeod SD, Porco TC, Acharya NR, Lietman TM. Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I. Invest Ophthalmol Vis Sci. 2013 Jun; 54(6):4167-73.
  10. Keenan JD, Emerson PM, Gaynor BD, Porco TC, Lietman TM. Adult mortality in a randomized trial of mass azithromycin for trachoma. JAMA Intern Med. 2013 May 13; 173(9):821-3.
  11. Oldenburg CE, Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Borkar DS, Ray KJ, Zegans ME, McLeod SD, Porco TC, Lietman TM, Acharya NR. Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India. Ophthalmic Epidemiol. 2013 Jun; 20(3):155-8.
  12. Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M, Raghavan A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Porco TC, Acharya NR, Lietman TM. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013 Apr; 131(4):422-9.
  13. Ray KJ, Prajna L, Srinivasan M, Geetha M, Karpagam R, Glidden D, Oldenburg CE, Sun CQ, McLeod SD, Acharya NR, Lietman TM. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmol. 2013 Mar; 131(3):310-3.
  14. Oldenburg CE, Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Mascarenhas J, Nardone N, Ray KJ, Glidden DV, Acharya NR, Lietman TM. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Invest Ophthalmol Vis Sci. 2013 Feb; 54(2):1522-6.
  15. Borkar DS, Fleiszig SM, Leong C, Lalitha P, Srinivasan M, Ghanekar AA, Tam C, Li WY, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis. JAMA Ophthalmol. 2013 Feb; 131(2):147-53.
  16. Amza A, Kadri B, Nassirou B, Yu SN, Stoller NE, Bhosai SJ, Zhou Z, McCulloch CE, West SK, Bailey RL, Keenan JD, Lietman TM, Gaynor BD. The easiest children to reach are most likely to be infected with ocular Chlamydia trachomatis in trachoma endemic areas of Niger. PLoS Negl Trop Dis. 2013; 7(1):e1983.
  17. Loh AR, Joseph D, Keenan JD, Lietman TM, Naseri A. Predictors of matching in an ophthalmology residency program. Ophthalmology. 2013 Apr; 120(4):865-70.
  18. McClintic SM, Srinivasan M, Mascarenhas J, Greninger DA, Acharya NR, Lietman TM, Keenan JD. Improvement in corneal scarring following bacterial keratitis. Eye (Lond). 2013 Mar; 27(3):443-6.
  19. Porco TC, Gao D, Scott JC, Shim E, Enanoria WT, Galvani AP, Lietman TM. When does overuse of antibiotics become a tragedy of the commons? PLoS One. 2012; 7(12):e46505.
  20. Amza A, Kadri B, Nassirou B, Stoller NE, Yu SN, Zhou Z, West SK, Mabey DC, Bailey RL, Keenan JD, Porco TC, Lietman TM, Gaynor BD. A cluster-randomized controlled trial evaluating the effects of mass azithromycin treatment on growth and nutrition in Niger. Am J Trop Med Hyg. 2013 Jan; 88(1):138-43.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.